U.S. markets closed

Titan Medical Inc. (TMDI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.5600-0.0700 (-4.29%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close1.6300
Open1.6700
Bid1.5600 x 900
Ask1.6000 x 3100
Day's Range1.4600 - 1.6200
52 Week Range0.2200 - 3.4700
Volume2,324,080
Avg. Volume4,058,238
Market Cap171.973M
Beta (5Y Monthly)4.63
PE Ratio (TTM)N/A
EPS (TTM)-0.3610
Earnings DateMay 11, 2021 - May 17, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-27% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Titan Medical to Present at Bloom Burton & Co. Healthcare Investor Conference
    Business Wire

    Titan Medical to Present at Bloom Burton & Co. Healthcare Investor Conference

    Titan Medical to Present at Bloom Burton & Co. Healthcare Investor Conference

  • Titan Medical to Participate in Upcoming Investor Conferences
    Business Wire

    Titan Medical to Participate in Upcoming Investor Conferences

    Titan Medical Inc. ("Titan" or the "Company") (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, today announced that, David McNally, President, CEO and Chairman and Monique Delorme, CFO of Titan Medical, will participate in two upcoming virtual investor conferences.

  • Titan Medical Issues Corporate Update
    Business Wire

    Titan Medical Issues Corporate Update

    Titan Medical Inc. ("Titan" or the "Company") (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, today announced a corporate update in conjunction with its presentation at the H.C. Wainwright Global Life Sciences Conference. David McNally, President, CEO and Chairman of Titan Medical, will provide an overview of the Company and its Enos™ robotic single access surgical system at the conference, which is available for on-demand access on Titan Medical’s website under the "Investors" section.